Synchronous multiple primary squamous cell carcinoma a rare entity by Mathew, Anuna Laila et al.
Vol 3 | Issue 4 | Oct - Dec 2017 Indian J Case Reports 261
Case Report
Synchronous multiple primary squamous cell carcinoma a rare entity
Anuna Laila Mathew1, Biju Baby Joseph2, M S Deepa2, Preeja Premkumar2, S Sunil3
From 1Departments of Oral Medicine and Radiology and 3Department of Oral Pathology, Pushpagiri College of Dental Sciences, Thiruvalla, Kerala, 
India, 2Departments of Oral Medicine and Radiology, Azeezia College of Dental Sciences and Research, Kollam, Kerala, India
Correspondence to: Anuna Laila Mathew, Departments of Oral Medicine and Radiology, Pushpagiri College of Dental Sciences, 
Thiruvalla, Kerala, India. E-mail: drmathewdan@yahoo.co.in
Received - 30 August 2017 Initial Review - 27 September 2017 Published Online - 27 October 2017
Squamous cell carcinoma (SCC) of the oral cavity is a common malignancy and has one of the lowest 5 years survival rates among all cancers. New surgical techniques, 
improved radiotherapy and use of concomitant chemotherapy, 
have not improved the survival rate over the last decades [1,2]. 
Head and neck cancer patients are at high risk of developing 
second primary tumors (SPTs) arising from the same dysplastic 
mucosal field. It was Lund in 1993, who first reported the 
presence of SPT only in 6% of patients with oral SCC [2,3]. Risk 
for second cancer in patients with oral-maxillofacial malignancies 
varies between 1.8 and 4.3% and up to 30% [4]. Warren and Gates 
[5] were the first to publish the criteria for the diagnosis of a SPT. 
Field concretization explains SPT as a progression from one or 
multiple precancerous lesions in morphologically abnormal tissue 
surrounding the tumor site [6]. This article describes an unusual 
case of multiple primary SCC in the oral mucosa in a chronic 
smoker and alcoholic and also discusses the clinical features and 
outcome of SPT.
CASE REPORT
A 45-year-old male reported to our department with the chief 
complaint of swelling on the right cheek of 5 months duration. 
Initially, it was small in size which has gradually increased in 
size with associated pain since 1 week. Pain is intermittent, 
sharp, and moderate and it radiates to the side of the head. 
Pain is aggravated on eating from the same side. No history of 
bleeding, pus discharge, fever, weight loss, swelling elsewhere in 
the body, loss of appetite, loss of taste, trauma, paresthesia, and 
mobility or loss of teeth. Past medical and dental histories were 
noncontributory. He had a habit of smoking 8 beedies per day and 
chewing betel quid 3 times per day for the 15 years. No history of 
alcohol consumption.
On examination, mouth opening was within the normal limits. 
Right submandibular lymph nodes were palpable, 2 in number, 
size 2 × 2 cm in size, hard, mobile, and tender. There was an ulcer-
proliferative growth on the right buccal mucosa in the posterior 
region measuring around 3 × 2 cm in size (Fig. 1). Surface appears 
granular covered with whitish slough. No bleeding or pus discharge. 
A similar growth adjacent to the first growth at a gap of 1.5 cm 
extending into the buccal sulcus was present. The clinical appearance 
was similar to that of the first growth. Growth is mildly tender on 
manipulation, and the base was indurated. A provisional diagnosis 
of malignancy of the right buccal mucosa and right vestibular sulcus 
in the region of posterior teeth was made (T2 NI Mo).
Panoramic radiograph revealed no bony involvement (Fig. 2). 
Incisional biopsy was done, and histopathological report showed a 
well-differentiated invasive SCC. A wide excision was done under 
general anesthesia, and specimen was sent for histopathological 
examination. It showed dysplastic stratified squamous epithelium 
invading into the underlying moderately collagenous and 
vascular connective tissue. The invading islands of epithelium 
showed well differentiation, which confirmed the diagnosis of 
well-differentiated SCC (Fig. 3). The patient was referred to 
Radiotherapy and Oncology Department for further management. 
Chemotherapy with concomitant boost radiotherapy was planned. 
Chemotherapy of 2 cycles with cisplatin 150 mg and radiotherapy 
of 54 Gy 30 fractions over 6 weeks and 18 Gy over 12 fractions 
were planned. The patient had an uneventful post-operative and 
post radiotherapy period. The patient was followed for a period 
of 2 years without any symptoms and signs and was then he lost 
to follow-up.
ABSTRACT
Second primary tumor (SPT)develops due to extensive initiation and promotion by various carcinogens such as tobacco and alcohol, 
leading to a widespread disorder of the epithelial maturation and differentiation with a field effect. Therefore, environmental factors 
which cause the development of the first tumor can probably cause the subsequent premalignant and malignant changes. This article 
describes an unusual case of metachronous multiple primary squamous cell carcinomas in the oral mucosa in a chronic smoker and 
alcoholic and also discusses the clinical features and outcome of SPT.
Key words: Buccal mucosa, Carcinoma, Multiple, Primary, Synchronous carcinomas
Mathew et al. Multiple primary squamous cell carcinoma 
Vol 3 | Issue 4 | Oct - Dec 2017 Indian J Case Reports 262
DISCUSSION
Based on the time of diagnosis, multiple tumors can be classified 
into synchronous (diagnosed simultaneously or within 6 months 
after the diagnosis of the index tumor)or metachronous (diagnosed 
after a time interval of 6 months) [3]. Cancer developing at 
the site of the initial malignancy at any time after treatment is 
a recurrence, regardless of the length of follow-up. Warren and 
Gates [5] studied several cases of multiple primary tumors arising 
from nonrelated sites and defined the criteria for a second primary 
carcinoma: Confirmation of malignancy in both tumors, each 
tumor must be distinct, and the second primary must be ruled 
out as metastatic spread from first cancer. The requirement for 
separation by normal non-neoplastic mucosa is at present often 
replaced by a distance of 2 cm [7].
Slaughter et al. in 1953, proposed the process of “field 
concretization,” referring to continuous exposure of the upper 
aerodigestive tract epithelium to unknown carcinogenic agents 
that lead to the development of multiple primary tumors [6]. For 
patients with carcinomas of the head and neck mucosal sites, the 
rates of developing synchronous and metachronous carcinomas 
range from 16 to 36%. SPT can share some or even all genetic 
markers with the index tumor, indicating that both tumors have 
arisen from a common clonal progenitor cell [9,10]. Patients 
with metachronous SPT located in the upper aerodigestive 
tract are thought to have a better prognosis than those with 
synchronous [11]. Cianfriglia et al. [3] reported that 90% of 
patients with synchronous oral SCCs are over than 40 years of age. 
About 40% of the second malignancies of the upper aerodigestive 
tract arise simultaneously and represent a synchronous tumor.
The 5 years survival rate decreases in patients with multiple 
primary tumors. Development of synchronous and metachronous 
SCC of the head and neck mucosal sites are in part responsible for 
justifying frequent follow-up and studies on chemoprevention. 
Despite marked improvements in locoregional control of head 
and neck SCC over the past 40 years, the overall 5 years survival 
rate has not changed since the 1960s, ranging from 40 to 50% 
and even that locoregional recurrence and distant metastasis 
collaborate to the low survival rate, the development of SPT also 
contributed with significant negative impact on the prognosis. 
Hence, patients treated for SCC require a long-term follow-up.
CONCLUSION
Our case did not show any signs or symptoms during the 2 years 
follow-up period so it can be assumed that with proper dietary 
modification, with stoppage of inadvertent habits along with 
the immunity might have contributed for the good prognosis 
of the lesion. However, a systematic follow-up protocol should 
be planned for such cases on a long duration basis which can 
contribute to the prognosis.
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